PRECISION OPTICS CORPORATION, INC. (POCI) Spending and interest coverage
- R&D / revenue · 12 months: Value 3.65%; Formula and calculation Research and development expense / revenue. Period ending 2026-03-31..
- Stock-based compensation / revenue · 12 months: Value 4.09%; Formula and calculation Share-based compensation / revenue. Period ending 2026-03-31..
- Interest coverage · 12 months: Value -29.75×; Formula and calculation Operating income ÷ reported interest expense..
Spending and interest coverage
Overview →Financial period ending 2026-03-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | 3.65% | Research and development expense / revenue. Period ending 2026-03-31. $1.06M ÷ $28.94M × 100 ≈ 3.65% |
| Stock-based compensation / revenue · 12 months | 4.09% | Share-based compensation / revenue. Period ending 2026-03-31. $1.18M ÷ $28.94M × 100 ≈ 4.09% |
| Interest coverage · 12 months | -29.75× | Operating income ÷ reported interest expense. $-4.76M ÷ $159.93K ≈ -29.75× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | 1.06M USD | Research and Development Expense |
| Revenue | 28.94M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | 1.18M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | -4.76M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | 159.93K USD | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: Reported. Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | $1.06M | $28.94M | $1.18M | $-4.76M | $159.93K | 3.65% | 4.09% | -29.75× | Reported |
| 2025-12-31 | $1.00M | $24.42M | $1.49M | $-6.73M | $183.29K | 4.10% | 6.11% | -36.73× | Reported |
| 2025-09-30 | $1.07M | $21.58M | $1.61M | $-5.90M | $204.49K | 4.96% | 7.47% | -28.85× | Reported |
| 2025-06-30 | $1.16M | $19.09M | $1.46M | $-5.55M | $227.02K | 6.07% | 7.65% | -24.45× | Reported |
| 2025-03-31 | $1.28M | $17.63M | $1.23M | $-5.55M | (m) | 7.29% | 6.98% | (m) | (m) |
| 2024-12-31 | $1.27M | $18.68M | $926.18K | $-3.77M | (m) | 6.77% | 4.96% | (m) | (m) |
| 2024-09-30 | $1.17M | $18.98M | $1.00M | $-3.57M | (m) | 6.16% | 5.27% | (m) | (m) |
| 2024-06-30 | $981.78K | $19.10M | $959.78K | $-2.72M | (m) | 5.14% | 5.02% | (m) | (m) |
| 2024-03-31 | $959.12K | $19.41M | $898.63K | $-1.98M | $223.77K | 4.94% | 4.63% | -8.86× | Reported |
| 2023-12-31 | $1.06M | $19.22M | $1.09M | $-2.22M | $213.37K | 5.52% | 5.67% | -10.39× | Reported |
| 2023-09-30 | $959.66K | $20.28M | $952.79K | $-942.04K | $221.13K | 4.73% | 4.70% | -4.26× | Reported |
| 2023-06-30 | $992.38K | $21.04M | $919.03K | $-638.55K | $218.93K | 4.72% | 4.37% | -2.92× | Reported |
| 2023-03-31 | $893.75K | $20.81M | $943.65K | $-444.47K | $218.81K | 4.29% | 4.53% | -2.03× | Reported |
| 2022-12-31 | $902.27K | $20.42M | $724.75K | $198.64K | $223.47K | 4.42% | 3.55% | 0.89× | Reported |
| 2022-09-30 | $806.77K | $18.43M | $830.41K | $-958.53K | $207.73K | 4.38% | 4.51% | -4.61× | Reported |
| 2022-06-30 | $666.48K | $15.68M | $915.49K | $-1.51M | $155.66K | 4.25% | 5.84% | -9.73× | Reported |
| 2022-03-31 | $613.89K | $13.56M | $1.16M | $-1.53M | $107.39K | 4.53% | 8.57% | -14.26× | Reported |
| 2021-12-31 | $545.06K | $11.36M | $1.02M | $-1.73M | (m) | 4.80% | 8.94% | (m) | (m) |
| 2021-09-30 | $577.86K | $10.25M | $822.86K | $-1.48M | $9.34K | 5.64% | 8.03% | -158.30× | Reported |
| 2021-06-30 | $624.25K | $10.67M | $733.93K | $-905.58K | $5.30K | 5.85% | 6.88% | -170.80× | Reported |
| 2021-03-31 | $629.13K | $10.24M | $389.82K | $-787.20K | (m) | 6.14% | 3.81% | (m) | (m) |
| 2020-12-31 | $802.95K | $10.15M | $379.36K | $-996.63K | (m) | 7.91% | 3.74% | (m) | (m) |
| 2020-09-30 | $885.55K | $10.17M | $496.99K | $-1.34M | (m) | 8.71% | 4.89% | (m) | (m) |
| 2020-06-30 | $886.13K | $9.92M | $502.35K | $-1.42M | $1.00K | 8.93% | 5.06% | -1420.14× | Reported |
| 2020-03-31 | $858.05K | $10.07M | $544.00K | $-1.21M | (m) | 8.52% | 5.40% | (m) | (m) |
| 2019-12-31 | $659.82K | $9.08M | $471.32K | $-825.64K | (m) | 7.27% | 5.19% | (m) | (m) |
| 2019-09-30 | $556.66K | $7.76M | $206.85K | $-399.64K | $1.14K | 7.17% | 2.67% | -350.87× | Reported |
| 2019-06-30 | $505.30K | $6.80M | $473.33K | $-612.54K | $1.42K | 7.43% | 6.96% | -432.59× | Reported |
| 2019-03-31 | $469.40K | $5.88M | $366.44K | $-486.25K | $1.56K | 7.98% | 6.23% | -311.10× | Reported |
| 2018-12-31 | $474.13K | $5.23M | $372.52K | $-684.89K | $1.71K | 9.06% | 7.12% | -401.23× | Reported |
| 2018-09-30 | $438.75K | $4.57M | $369.27K | $-619.13K | $1.85K | 9.60% | 8.08% | -335.03× | Reported |
| 2018-06-30 | $456.38K | $4.04M | $52.34K | $-348.62K | $1.86K | 11.30% | 1.30% | -187.53× | Reported |
| 2018-03-31 | $440.46K | $3.30M | $88.87K | $-602.32K | $2.75K | 13.36% | 2.70% | -219.27× | Reported |
| 2017-12-31 | $436.41K | $3.54M | $124.21K | $-485.01K | $4.14K | 12.31% | 3.50% | -117.10× | Reported |
| 2017-09-30 | $465.60K | $3.33M | $166.77K | $-737.26K | $3.66K | 13.97% | 5.00% | -201.44× | Reported |
| 2017-06-30 | $464.16K | $3.15M | $201.61K | $-1.00M | $3.14K | 14.71% | 6.39% | -318.83× | Reported |
| 2017-03-31 | $459.59K | $3.40M | $202.00K | $-915.57K | $1.84K | 13.53% | 5.95% | -496.78× | Reported |
| 2016-12-31 | $455.56K | $3.55M | $209.39K | (m) | (m) | 12.82% | 5.89% | (m) | (m) |
| 2016-09-30 | $444.49K | $3.91M | $201.97K | (m) | (m) | 11.37% | 5.17% | (m) | (m) |
| 2016-06-30 | $478.27K | $3.92M | $241.39K | $-1.06M | $469.00 | 12.21% | 6.16% | -2250.39× | Reported |
| 2016-03-31 | $514.35K | $3.92M | $277.06K | $-1.27M | (m) | 13.13% | 7.07% | (m) | (m) |
| 2015-12-31 | $536.25K | $3.92M | $227.98K | (m) | (m) | 13.69% | 5.82% | (m) | (m) |
| 2015-09-30 | $566.99K | $3.94M | $199.00K | (m) | (m) | 14.39% | 5.05% | (m) | (m) |
| 2015-06-30 | $492.94K | $3.91M | $125.67K | $-1.21M | (m) | 12.60% | 3.21% | (m) | (m) |
| 2015-03-31 | $466.88K | $3.85M | $74.86K | $-1.17M | (m) | 12.12% | 1.94% | (m) | (m) |
| 2014-12-31 | $459.66K | $3.54M | $113.94K | (m) | (m) | 12.97% | 3.22% | (m) | (m) |
| 2014-09-30 | $412.90K | $3.57M | $134.42K | (m) | (m) | 11.55% | 3.76% | (m) | (m) |
| 2014-06-30 | $471.11K | $3.65M | $141.03K | $-1.16M | $0.00 | 12.90% | 3.86% | (m) | Reported |
| 2014-03-31 | $456.88K | $3.55M | $143.43K | $-1.02M | $0.00 | 12.87% | 4.04% | (m) | Reported |
| 2013-12-31 | $483.40K | $3.37M | $154.62K | $-985.36K | $0.00 | 14.33% | 4.58% | (m) | Reported |
| 2013-09-30 | $557.92K | $2.86M | $131.52K | $-1.09M | $158.00 | 19.48% | 4.59% | -6875.86× | Reported |
| 2013-06-30 | $630.29K | $2.52M | $108.42K | $-1.23M | $1.41K | 25.01% | 4.30% | -875.36× | Reported |
| 2013-03-31 | $699.28K | $2.49M | $100.10K | $-1.28M | $2.66K | 28.09% | 4.02% | -481.04× | Reported |
| 2012-12-31 | $738.41K | $2.22M | $81.46K | $-1.42M | $3.91K | 33.32% | 3.68% | -363.23× | Reported |
| 2012-09-30 | $720.80K | $2.21M | $76.85K | $-1.38M | $16.46K | 32.60% | 3.48% | -83.75× | Reported |
| 2012-06-30 | $664.70K | $2.15M | $78.34K | $-1.28M | $30.21K | 30.88% | 3.64% | -42.53× | Reported |
| 2012-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-06-30 | $825.03K | $2.25M | $22.70K | $-991.91K | $60.00K | 36.75% | 1.01% | -16.53× | Reported |
| 2011-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| ENDRA Life Sciences Inc. (NDRA) | United States | $0.009B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| Nuwellis, Inc. (NUWE) | United States | $0.003B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B |